Armstrong, A. J., Petrylak, D. P., Shore, N. D., Szmulewitz, R. Z., Holzbeierlein, J. M., Villers, A., Alcaraz, A., Alekseev, B., Iguchi, T., Gomez-Veiga, F., Serikoff, A., Croitoru, R., Rosales, M., Kalac, M., Tang, Y., Stenzl, A., Azad, A. (2026). Predictors of treatment (tx) duration in patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) treated with enzalutamide (ENZA): A post hoc analysis of ARCHES.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5093